| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/29/1994 | WO1994021275A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 09/29/1994 | WO1994021252A1 Taxanes having a pyridyl substituted side-chain |
| 09/29/1994 | WO1994021251A1 Taxanes having an amino substituted side-chain |
| 09/29/1994 | WO1994021250A1 Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 09/29/1994 | WO1994021240A2 Superparamagnetic particles, process for producing the same and their use |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994021232A1 Water dispersible therapeutic compounds |
| 09/29/1994 | WO1994021231A1 Therapeutic agent for the treatment of melanomas |
| 09/29/1994 | WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/29/1994 | WO1994015958A3 Peptide inhibitors of cell adhesion |
| 09/29/1994 | WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/29/1994 | WO1994011522A3 Vector for the expression of therapy-relevant genes |
| 09/29/1994 | CA2159085A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | CA2158655A1 Process for preparing cancer vaccines |
| 09/29/1994 | CA2158546A1 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | CA2158281A1 Peptide coated dendritic cells as immunogens |
| 09/29/1994 | CA2157758A1 Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine |
| 09/29/1994 | CA2155842A1 Novel heterocycles, their preparation and their use |
| 09/28/1994 | EP0617124A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 09/28/1994 | EP0617034A1 2-Debenzoyl-2-acyl taxol derivatives and methods for making same |
| 09/28/1994 | EP0617030A1 Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes |
| 09/28/1994 | EP0617024A1 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof |
| 09/28/1994 | EP0617018A1 Beta-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes |
| 09/28/1994 | EP0616813A2 Antitumor mitoxantrone polymeric compositions |
| 09/28/1994 | EP0616641A1 Humanized b-b10, an anti-il2 receptor antibody |
| 09/28/1994 | EP0616536A1 INHIBITING TRANSFORMING GROWTH FACTOR $g(b) TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 09/28/1994 | EP0616533A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 09/28/1994 | EP0616493A1 Methods and compositions for reducing multi-drug resistance |
| 09/28/1994 | EP0340243B1 Cc-1065 analogs |
| 09/28/1994 | CN1025983C Macrocyclic aminophosphonic acid complexes, their preparation formulations and use |
| 09/27/1994 | US5350867 Treatment of cancer |
| 09/27/1994 | US5350840 Diagnosis |
| 09/26/1994 | CA2119675A1 Antitumor mitoxantrone polymeric compositions |
| 09/25/1994 | CA2119530A1 Pharmaceutical compounds |
| 09/21/1994 | EP0615548A1 Novel proteases with dna fragmenting activity |
| 09/21/1994 | EP0615448A1 Sex steroid activity inhibitors |
| 09/21/1994 | EP0558623B1 Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same |
| 09/21/1994 | EP0440688B1 Cpf peptide compositions and uses |
| 09/21/1994 | CN1092424A Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 09/21/1994 | CN1092417A Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 09/21/1994 | CN1092416A Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them |
| 09/20/1994 | US5349112 Cyclic anti-tumor promoter compounds, compositions and methods for production and use |
| 09/20/1994 | US5349066 Bifunctional linking compounds, conjugates and methods for their production |
| 09/20/1994 | US5349064 Production of pyrrolopyrimidines |
| 09/20/1994 | US5348950 Platinum(II) complex and antitumor agent |
| 09/20/1994 | US5348949 Method of preparing N-oxo-tetrahydro-β-carbolines |
| 09/20/1994 | US5348864 Mouse vav proto-oncogene DNA and protein sequences |
| 09/20/1994 | US5348739 Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonists |
| 09/20/1994 | CA2116093A1 .beta.-lactams, methods for the preparation of taxanes and sidechain bearing taxanes |
| 09/15/1994 | WO1994020859A1 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor |
| 09/15/1994 | WO1994020625A1 Method for inducing tumor cell death |
| 09/15/1994 | WO1994020618A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 09/15/1994 | WO1994020540A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 09/15/1994 | WO1994020532A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 09/15/1994 | WO1994020486A1 Method and apparatus for extracting taxol from source materials |
| 09/15/1994 | WO1994020485A1 Process for the preparation of 9-desoxotaxanes |
| 09/15/1994 | WO1994020484A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 09/15/1994 | WO1994020467A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 09/15/1994 | WO1994020463A1 Novel distamycin analogues |
| 09/15/1994 | WO1994020142A1 Assays and therapeutic methods based on lymphocyte chemoattractants |
| 09/15/1994 | WO1994020140A1 COMPOSITONS COMPRISING IgG3 ANTIBODIES |
| 09/15/1994 | WO1994020137A1 Production of human papillomavirus capsid protein and virus-like particles |
| 09/15/1994 | WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/15/1994 | WO1994020107A1 Rejection inhibitor for transplants and il-1 production inhibitor |
| 09/15/1994 | WO1994020101A1 Antitumor compositions and methods of treatment |
| 09/15/1994 | WO1994020095A1 Biologically active ureido derivatives useful as antimetastatic agents |
| 09/15/1994 | WO1994020093A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 09/15/1994 | WO1994020088A1 C9 taxane derivatives and pharmaceutical compositions containing them |
| 09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
| 09/15/1994 | WO1994020062A2 Balanoids as protein kinase c inhibitors |
| 09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
| 09/15/1994 | WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 09/15/1994 | WO1994011010A3 Compositions of oak bark extract, related synthetic compositions, and method of using same |
| 09/15/1994 | CA2158050A1 Method and apparatus for extracting taxol from source materials |
| 09/15/1994 | CA2157868A1 Diagnostic kit for a cancer producing hcg or hcg fragments; methods used for the immunotherapy of said cancer |
| 09/15/1994 | CA2157863A1 Compositions comprising igg3 antibodies |
| 09/15/1994 | CA2157801A1 Antitumor compositions and methods of treatment |
| 09/15/1994 | CA2157798A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 09/15/1994 | CA2157770A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 09/15/1994 | CA2157412A1 Balanoids |
| 09/15/1994 | CA2157187A1 Novel distamycin analogues |
| 09/15/1994 | CA2157010A1 Method for inducing tumor cell death |
| 09/15/1994 | CA2156729A1 New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compounds |
| 09/15/1994 | CA2134880A1 Graft rejection inhibitor and il-1 production inhibitor |
| 09/15/1994 | CA2134098A1 Biologically active ureido derivatives useful as antimetastatic agents |
| 09/14/1994 | EP0614978A1 Soluble human Fcgamma receptors, method to prepare them, pharmaceutical compositions containing them, their use as drugs and their diagnostic use |
| 09/14/1994 | EP0614975A1 Glycoprotein hormone receptor molecules |
| 09/14/1994 | EP0614893A1 Benzoazine derivatives, their preparation and their use in therapy |
| 09/14/1994 | EP0614887A1 Indole-sulfonamides as antitumor agents |
| 09/14/1994 | EP0614662A1 Use of (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid for the treatment of leukaemia |
| 09/14/1994 | EP0614661A2 Benzylidene- and cinnamylidine-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells |
| 09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 09/14/1994 | EP0614457A1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments. |
| 09/14/1994 | EP0614456A1 1$g(a),24(S)-DIHYDROXY VITAMIN D 2?, ITS FORMATION AND USE |
| 09/14/1994 | EP0614377A1 Method for diagnosing and treating cancer |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 09/14/1994 | EP0614366A1 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours. |
| 09/14/1994 | EP0614365A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |